What as‑needed (PRN) medication and dosing should be used for an adult with acute anxiety episodes, and how should it be adjusted for substance misuse, hepatic impairment, or pregnancy?

PRN Anti-Anxiety Medications for Acute Anxiety Episodes in Adults

For acute anxiety episodes in adults, lorazepam 0.5-1 mg orally (or sublingually) every 4-6 hours as needed is the first-line PRN medication, with a maximum of 4 mg in 24 hours. 1

Standard Dosing Algorithm

Primary recommendation:

• Lorazepam 0.5-1 mg orally four times daily PRN (maximum 4 mg/24 hours) 1
• Oral tablets can be used sublingually for faster onset 1
• For elderly or debilitated patients: reduce to 0.25-0.5 mg (maximum 2 mg/24 hours) 1

Alternative if unable to swallow:

• Midazolam 2.5-5 mg subcutaneously every 2-4 hours PRN 1
• If needed more than twice daily, consider continuous subcutaneous infusion starting at 10 mg over 24 hours 1

Special Population Adjustments

Hepatic Impairment

Benzodiazepines carry significant risk in severe liver disease and should be used with extreme caution 2. When absolutely necessary:

• Reduce lorazepam dose to 0.25-0.5 mg PRN
• Consider quetiapine 25 mg PO as alternative (reduce dose in hepatic impairment) 2
• Avoid chlorpromazine and use caution with all hepatically metabolized agents 2

Substance Misuse History

Benzodiazepines are contraindicated in patients with history of substance dependence (except for alcohol/benzodiazepine withdrawal treatment) 2. Instead:

• First-line: Quetiapine 25 mg PO PRN (less abuse potential) 2
• Second-line: Olanzapine 2.5-5 mg PO PRN 2
• Avoid combining benzodiazepines with antipsychotics due to oversedation risk 2

Pregnancy

Non-pharmacological interventions (cognitive-behavioral therapy) should be first-line in pregnancy 3. When medication is unavoidable:

• Use lowest effective dose for shortest duration
• SSRIs (sertraline, escitalopram) preferred over benzodiazepines for ongoing anxiety management 3
• If benzodiazepine necessary: lorazepam 0.25-0.5 mg PRN (minimize exposure, especially first trimester)
• Vigilant monitoring for neonatal withdrawal if used near delivery 3

Renal Impairment (eGFR <30 mL/min)

• Reduce midazolam infusion dose to 5 mg over 24 hours 1
• Lorazepam preferred over other benzodiazepines (no active metabolites)

Critical Safety Considerations

Common pitfalls to avoid:

1. Parenteral administration increases adverse events 7-10 fold compared to oral routes 4. Always offer oral medication first, including liquid formulations.

2. Co-administration of benzodiazepines with antipsychotics significantly increases risk of oversedation, respiratory depression, and falls—particularly dangerous in elderly 2, 4. Fatalities reported with benzodiazepine + high-dose olanzapine 2.

3. PRN benzodiazepine use paradoxically may increase dependence risk and reduce long-term anxiolytic efficacy 5. Limit prescriptions to short courses (ideally <2-4 weeks maximum) 6.

4. Benzodiazepines themselves can cause or worsen delirium, paradoxical agitation, and cognitive impairment 2—particularly in elderly, those with COPD, or when combined with other sedating medications.

5. Midazolam has the worst safety profile among benzodiazepines in older adults, with excessive adverse event rates 4. Lorazepam is safer for PRN use.

Monitoring Requirements

• Assess for falls risk, especially in elderly (increased risk with all benzodiazepines) 2
• Monitor for paradoxical agitation, drowsiness, respiratory depression 2
• If using >2 doses daily, reassess need and consider scheduled dosing or alternative approaches 2
• Evaluate for dependence if use extends beyond 2-4 weeks 6

When Benzodiazepines Are Contraindicated

Absolute cautions (unless imminently dying patient):

• Severe pulmonary insufficiency
• Severe liver disease
• Myasthenia gravis
• History of substance dependence (except treating withdrawal) 2